Development of monoclonal antibody imaging of metastatic prostatic carcinoma

Frederick J Meyers, S. J. Denardo, D. Macey, Ralph W deVere White, M. Unger

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Indium-111-labeled monoclonal antibody directed against prostate-specific antigen was injected into ten patients with known prostatic carcinoma, nine with metastatic disease. The monoclonal antibody scan was compared to the standard technetium bone scan, and both were correlated to clinical status and to 2-year follow-up. The ratio of target-to-nontarget activity and pharmacokinetics of the radiolabeled antibody approach may be used for staging and may be developed as a therapeutic adjuvant.

Original languageEnglish (US)
Pages (from-to)209-220
Number of pages12
Issue number3
StatePublished - 1989

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Development of monoclonal antibody imaging of metastatic prostatic carcinoma'. Together they form a unique fingerprint.

Cite this